PKM and cancer: PKM2 is the most powerful and widely studied subtype and has abnormally high expression in many cancers, such as colorectal tumors, breast tumors, lung tumors, prostate tumors, and ovarian tumors, while the expression levels in the pharynx and testicular tumors are below or close to the critical value (Munoz-Colmenero et al., 2015).